Västra Hamnen: ViroGates - Steadily growing customer base
Västra Hamnen Corporate Finance has published a research update on ViroGates following its Quarterly Report for Q2 2020. The numbers were in line with our expectations, and we look positively on the newly added clinical routine customers, writes Västra Hamnen.• Increasing attention on efficient triaging due to COVID-19 pandemic• Currently ten clinical routine customers• We keep our valuation interval unchanged at DKK 68.00 – 100.50 per share ViroGates’ report for Q2 2020 came in almost exactly in line with our forecasts.Revenues, although markedly lower than a year ago, were